dr. reddy's labs glp-1 receptor agonists weight management diabetes treatments Dr Launches Oral Semaglutide in India Oral GLP-1-Based Therapeutics in the

The Global GLP-1 Receptor Agonists Obesity Drugs Market was valued at USD 9.96 Billion in 2024 and is expected to reach USD 33.12 Billion by 2032, growing at a CAGR of 16.20% (2025-2032).

This wildly popular drug is a synthetic form of GLP-1 (glucagon-like peptide-1), a hormone that regulates blood sugar and curbs appetite

Tirzepatide & Semaglutide Options Price: Starting at $100/month

This breakthrough formula fires up GLP-1 production to fend off cravings, especially those carb-loaded temptations

Afternoon fatigue and brain fog

While natural approaches to raising GLP-1 are not as potent as medications, they provide a drug-free approach to weight loss and healthy eating.